Digoxin Discontinuation in Patients with HFrEF on Beta-Blockers: Implication for Future “Knock-Out Trials” in Heart Failure

Lam PH, Liu K, Ahmed AA, Butler J, Heidenreich PA, Anker MS, Faselis C, Deedwania P, Aronow WS, Kanonidis I, Masson R, Gill GS, Morgan CJ, Arundel C, Allman RM, Wu WC, Fonarow GC, Ahmed A. Digoxin Discontinuation in Patients with HFrEF on Beta-Blockers: Implication for Future "Knock-Out Trials" in Heart Failure. Am J Med. 2024 Oct 16:S0002-9343(24)00638-7. doi: 10.1016/j.amjmed.2024.10.015. Epub ahead of print. PMID: 39424217.


Related Posts